Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,204 | 507 | 99.0% |
| Education | $129.13 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,027 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,753 | 30 | $0 (2022) |
| PFIZER INC. | $1,310 | 83 | $0 (2024) |
| ABBVIE INC. | $739.20 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $736.75 | 26 | $0 (2024) |
| Gilead Sciences, Inc. | $677.23 | 8 | $0 (2019) |
| GlaxoSmithKline, LLC. | $662.77 | 25 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $536.79 | 17 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $463.22 | 13 | $0 (2019) |
| Amgen Inc. | $411.44 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $855.60 | 28 | Amgen Inc. ($264.82) |
| 2023 | $1,102 | 41 | GlaxoSmithKline, LLC. ($167.12) |
| 2022 | $1,402 | 73 | ABBVIE INC. ($238.69) |
| 2021 | $1,835 | 89 | AbbVie Inc. ($294.98) |
| 2020 | $707.90 | 44 | AstraZeneca Pharmaceuticals LP ($167.04) |
| 2019 | $1,722 | 53 | AstraZeneca Pharmaceuticals LP ($390.73) |
| 2018 | $2,229 | 82 | Janssen Pharmaceuticals, Inc ($469.21) |
| 2017 | $3,480 | 106 | Janssen Pharmaceuticals, Inc ($640.64) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Respiratory | ||||||
| 08/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardio-renal | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 08/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $139.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: PAIN | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $140.12 | General |
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 777 | 1,146 | $134,598 | $58,777 |
| 2022 | 22 | 964 | 1,593 | $175,547 | $84,227 |
| 2021 | 26 | 1,055 | 1,675 | $152,154 | $77,631 |
| 2020 | 36 | 1,477 | 6,225 | $302,562 | $137,097 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 353 | $73,868 | $28,387 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 64 | $15,713 | $6,325 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $8,013 | $5,499 | 68.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $13,651 | $4,518 | 33.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 48 | 48 | $4,752 | $3,720 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 34 | $4,270 | $1,894 | 44.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 47 | 47 | $1,457 | $1,154 | 79.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 30 | 68 | $2,244 | $1,103 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 115 | $1,523 | $966.00 | 63.4% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 19 | 19 | $2,090 | $955.32 | 45.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 49 | 49 | $1,029 | $848.68 | 82.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 21 | $1,302 | $825.30 | 63.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $946.00 | $779.40 | 82.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 16 | $912.00 | $500.92 | 54.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 12 | $372.00 | $291.00 | 78.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 28 | $812.00 | $276.38 | 34.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 59 | 81 | $608.00 | $276.21 | 45.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 15 | $600.00 | $243.00 | 40.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 19 | 20 | $220.00 | $122.20 | 55.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 18 | $216.00 | $91.44 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 426 | $84,425 | $33,947 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 78 | $17,549 | $8,519 | 48.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 137 | $13,700 | $7,299 | 53.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $7,517 | $5,417 | 72.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $12,853 | $4,894 | 38.1% |
About Dr. Temidayo Adelekun, MD
Dr. Temidayo Adelekun, MD is a Internal Medicine healthcare provider based in Kings Mountain, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962497537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Temidayo Adelekun, MD has received a total of $13,333 in payments from pharmaceutical and medical device companies, with $855.60 received in 2024. These payments were reported across 516 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($13,204).
As a Medicare-enrolled provider, Adelekun has provided services to 4,273 Medicare beneficiaries, totaling 10,639 services with total Medicare billing of $357,731. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Kings Mountain, NC
- Active Since 09/20/2005
- Last Updated 08/24/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962497537
Products in Payments
- FARXIGA (Drug) $1,148
- INVOKANA (Drug) $935.48
- XARELTO (Drug) $811.24
- JARDIANCE (Drug) $661.03
- NURTEC ODT (Drug) $486.29
- ENTRESTO (Drug) $423.53
- KRYSTEXXA (Biological) $381.38
- CHANTIX (Drug) $380.91
- VRAYLAR (Drug) $338.83
- UBRELVY (Drug) $323.24
- LYRICA (Drug) $313.91
- EUCRISA (Drug) $274.15
- TOUJEO (Drug) $266.68
- BREZTRI (Drug) $264.68
- TRELEGY ELLIPTA (Drug) $249.48
- Epclusa (Drug) $209.71
- BYDUREON (Drug) $206.67
- XIFAXAN (Drug) $204.60
- SOLIQUA (Drug) $196.54
- Kerendia (Drug) $170.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kings Mountain
Gaurang Palikh, M.d, M.D
Internal Medicine — Payments: $2,209
Dr. Everette Thombs, Md, MD
Internal Medicine — Payments: $1,330
Dr. Byron Leak, Md, MD
Internal Medicine — Payments: $55.00
Charles Langley, Md, MD
Internal Medicine
Laurence Kish, Md, MD
Internal Medicine
Anton Bazarov, Md, MD
Internal Medicine